Canadian Pharmaceuticals & Biotech Big Green Snowflakes

Steep Hill

Market Cap: CA$808.9k

Does not have significant operations.

Digicann Ventures

Market Cap: CA$441.1k

Operates in the cannabis industry.

NurExone Biologic

Market Cap: CA$67.6m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

Quantum BioPharma

Market Cap: CA$76.5m

Operates as a biopharmaceutical company.

iAnthus Capital Holdings

Market Cap: CA$33.9m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Crescita Therapeutics

Market Cap: CA$9.1m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Entheon Biomedical

Market Cap: CA$1.2m

Operates as a biotechnology research and development company.

Theratechnologies

Market Cap: CA$206.9m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

TILT Holdings

Market Cap: CA$2.0m

Provides various cannabis products and services in the United States, Canada, and internationally.

Sernova Biotherapeutics

Market Cap: CA$57.5m

Operates as a clinical-stage biotechnology company in Canada.

Verano Holdings

Market Cap: CA$633.1m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Captor Capital

Market Cap: CA$1.7m

Engages in the retail sale of cannabis products in the United States.

Avant Brands

Market Cap: CA$9.3m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Thiogenesis Therapeutics

Market Cap: CA$44.7m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Light AI

Market Cap: CA$28.2m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

Pharmala Biotech Holdings

Market Cap: CA$13.9m

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Cresco Labs

Market Cap: CA$698.6m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Vext Science

Market Cap: CA$68.1m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Restart Life Sciences

Market Cap: CA$3.1m

Through its subsidiaries, operates as a biotechnology company worldwide.

Telescope Innovations

Market Cap: CA$20.1m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Vaxil Bio

Market Cap: CA$465.7k

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

Vireo Growth

Market Cap: CA$626.9m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Sona Nanotech

Market Cap: CA$66.5m

Operates as a nanotechnology life sciences company.

Telo Genomics

Market Cap: CA$7.5m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions primarily in Canada.

PharmaTher Holdings

Market Cap: CA$34.6m

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

Atlas Energy

Market Cap: CA$97.6m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

ME Therapeutics Holdings

Market Cap: CA$118.4m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.

Grown Rogue International

Market Cap: CA$149.7m

A craft cannabis company, focuses on premium flower and flower-derived products.

COSCIENS Biopharma

Market Cap: CA$10.9m

A life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally.

Canopy Growth

Market Cap: CA$595.9m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

TerrAscend

Market Cap: CA$399.3m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Voyageur Pharmaceuticals

Market Cap: CA$28.5m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

MTL Cannabis

Market Cap: CA$78.4m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

1933 Industries

Market Cap: CA$5.0m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Lobe Sciences

Market Cap: CA$10.0m

A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.